Research Studies & News

Latest research findings, clinical studies, and news about vasculitis treatment and awareness.

Staying informed about the latest vasculitis research helps patients and caregivers make better decisions about treatment and care.

News

Vasculitis and rare-disease coverage in the media, and our doctors in conversation.

In the News · NewsX

ANS 3.0: Dr. Aman Sharma Says India Is Now Leading Global Healthcare Research

In a NewsX exclusive from ANS 3.0, Dr. Aman Sharma — Professor of Clinical Immunology & Rheumatology at PGIMER, Chandigarh — talks about India's growing role in global healthcare research and what it means for patients living with rare and autoimmune conditions.

Research Studies

Plain-language summaries of recent published research on vasculitis.

Research Study · 2024

Close Monitoring During Pregnancy is Critical to Improving Feto-maternal Outcomes in Takayasu Arteritis

Takayasu arteritis predominantly affects young females of child-bearing age. This study examines how close monitoring during pregnancy can improve outcomes for both mother and baby...

Researchers studying AAV and cancer risk

Research Study · 2024

A Turkish Study Has Discovered That Men with AAV Have a Threefold Increase in Cancer Risk

Men with ANCA-associated vasculitis are three times more likely to develop cancer than age-matched men in the general population, with lung and head and neck cancers being most common...

Researchers examining blood samples under microscope

Research Study · 2024

Risk of Renal Failure Evident in Those with Low Platelet Levels at Early Disease Stage

Low platelet counts at the time of AAV diagnosis may signal poorer kidney function and a higher risk of kidney failure, according to a retrospective study from China...

Research team in laboratory studying AAV treatment

Research Study · 2024

Tavneos Linked to Remission in ANCA-Associated Vasculitis

Tavneos (avacopan) safely promotes clinical remission in AAV patients. Real-world remission rates after one year were higher than those seen in the Phase 3 ADVOCATE trial (84% vs. 65.7%)...

Medical Disclaimer: Research summaries here are for general educational purposes only and should not replace professional medical advice. Always consult your rheumatologist before making any treatment decisions.

Stay Updated

Facebook Instagram YouTube